|
Usage and factors associated with adjuvant bisphosphonate therapy among postmenopausal women diagnosed with early-stage breast cancer. |
|
Veera Durga Sravanthi Panuganty |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Roche Canada |
Travel, Accommodations, Expenses - Roche Canada |
|
|
|
Consulting or Advisory Role - Lilly |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |